G01N 33/60
Involving radioactive labelled substances
Official title: involving radioactive labelled substances
G01N33/60 (Involving radioactive labelled substances) appears on 420 US grants and 511 published applications in this corpus.
Search patents in G01N- Granted patents
- 420
- Published applications
- 511
- Assignees
- 346
- Inventors
- 1,266
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 4 | 0 |
| 1979 | 7 | 0 |
| 1980 | 7 | 0 |
| 1981 | 13 | 0 |
| 1982 | 12 | 0 |
| 1983 | 3 | 0 |
| 1984 | 8 | 0 |
| 1985 | 2 | 0 |
| 1986 | 3 | 0 |
| 1987 | 7 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 12 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 6 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 9 |
| 2003 | 3 | 33 |
| 2004 | 5 | 15 |
| 2005 | 3 | 13 |
| 2006 | 6 | 14 |
| 2007 | 6 | 18 |
| 2008 | 5 | 12 |
| 2009 | 3 | 13 |
| 2010 | 5 | 19 |
| 2011 | 8 | 14 |
| 2012 | 8 | 13 |
| 2013 | 9 | 16 |
| 2014 | 11 | 24 |
| 2015 | 11 | 20 |
| 2016 | 20 | 27 |
| 2017 | 18 | 28 |
| 2018 | 15 | 27 |
| 2019 | 25 | 37 |
| 2020 | 21 | 26 |
| 2021 | 27 | 28 |
| 2022 | 18 | 35 |
| 2023 | 12 | 19 |
| 2024 | 13 | 24 |
| 2025 | 16 | 17 |
| 2026 | 9 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Theragnostic method for cancer patients15 Sep 2026US 12,734,257 B2
- Chemically cleavable group15 Sep 2026US 12,735,444 B2Tagworks Pharmaceuticals B.V.
- Antibodies against human and canine IL-13RA225 Aug 2026US 12,715,926 B2Wake Forest University Health Sciences
- Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography9 Jun 2026US 12,649,752 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Detection of symmetrical dimethylarginine9 Jun 2026US 12,650,433 B2IDEXX Laboratories, Inc.
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Blood staining patch, method and device for blood test using the same18 Jun 2026US 2026/0168895 A1Noul Co., Ltd.
- Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds28 May 2026US 2026/0144904 A1Smith College
- Mouse Anti-Human Monoclonal Antibody Against Glypican-314 May 2026US 2026/0131035 A1Fred Hutchinson Cancer Center
- 68ga- and 64cu -nodaga-e[c(rgdyk)]2 for use as pet tracers in the imaging of angiogenesis in humans23 Apr 2026US 2026/0108638 A1Rigshospitalet
Most cited
By later US patents
- Manufacture and expression of structural genes153US 4,652,639 AAmgen Inc. · 1987
- Ultralow background multiple photon detector104US 5,866,907 ABioTraces, Inc. · 1999
- Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group99US 4,707,352 AEnzo Biochem, Inc. · 1987
- E2 displacement assay for identifying inhibitors of HPV74US 6,825,176 B2Boehringer Ingelheim (Canada) Ltd. · 2004
- Derivatized gold clusters and antibody-gold cluster conjugates73US 5,360,895 AAssociated Universities, Inc. · 1994